Solli, Ann Iren
SYDLER REMEDIES PVT LTD.
Vice President, Finance and Treasurer in June 2014 in connection with our spin‑off from Theravance, Inc., became Senior Vice President, Finance in July 2014 and became Senior Vice President and Chief Financial Officer in December 2014. Ms. Galá is responsible for finance and accounting, IT, and facilities activities. Prior to the Spin‑Off, Ms. Galá had been Vice President, Finance at Theravance, Inc. since January 2013. Ms. Galá joined Theravance, Inc. in June 2006, initially as Director of Financial Planning and Analysis and then as Senior Director of Finance and Procurement in July 2008. From 2001 to 2006, Ms. Galá worked at Eli Lilly and Company, where she held positions of increasing responsibility in global treasury, pharmaceutical sales, and corporate strategy/business development. Prior to joining Eli Lilly, she spent seven years in the energy industry in the U.S. and internationally in positions focused on corporate finance, project finance, and mergers and acquisitions. She is a member of the board of directors of Corcept Therapeutics Incorporated. Ms. Galá earned a B.S. in Mathematics from Vanderbilt University and an M.B.A. from Columbia Business School.